Similar articles for PMID: 25466707

Year	Number of Results
1988	1
1997	1
1998	1
2000	2
2001	1
2003	1
2004	4
2005	2
2006	6
2008	3
2009	6
2010	3
2011	3
2012	2
2013	5
2014	5
2015	7
2016	9
2017	3
2018	2
2019	1
2021	1
2023	1
2024	0

1

Economics of Malignant Gliomas: A Critical Review.

Raizer JJ, Fitzner KA, Jacobs DI, Bennett CL, Liebling DB, Luu TH, Trifilio SM, Grimm SA, Fisher MJ, Haleem MS, Ray PS, McKoy JM, DeBoer R, Tulas KM, Deeb M, McKoy JM. Raizer JJ, et al. J Oncol Pract. 2015 Jan;11(1):e59-65. doi: 10.1200/JOP.2012.000560. Epub 2014 Dec 2. J Oncol Pract. 2015. PMID: 25466707 Free PMC article.

2

Cost of temozolomide therapy and global care for recurrent malignant gliomas followed until death.

Wasserfallen JB, Ostermann S, Leyvraz S, Stupp R. Wasserfallen JB, et al. Neuro Oncol. 2005 Apr;7(2):189-95. doi: 10.1215/S1152851704000687. Neuro Oncol. 2005. PMID: 15831237 Free PMC article. Clinical Trial.

3

Economic evaluation of temozolomide in the treatment of recurrent glioblastoma multiforme.

Martikainen JA, Kivioja A, Hallinen T, Vihinen P. Martikainen JA, et al. Pharmacoeconomics. 2005;23(8):803-15. doi: 10.2165/00019053-200523080-00006. Pharmacoeconomics. 2005. PMID: 16097842

4

Direct medical costs of treatment in newly-diagnosed high-grade glioma among commercially insured US patients.

Jiang S, Hill K, Patel D, Waldeck AR, Botteman M, Aly A, Norden AD. Jiang S, et al. J Med Econ. 2017 Dec;20(12):1237-1243. doi: 10.1080/13696998.2017.1364258. Epub 2017 Aug 16. J Med Econ. 2017. PMID: 28777020 Free article.

5

Re-evaluation of the cost effectiveness of temozolomide for malignant gliomas in British Columbia.

Mabasa VH, Taylor SC. Mabasa VH, et al. J Oncol Pharm Pract. 2006 Jun;12(2):105-11. doi: 10.1177/1078155206069161. J Oncol Pharm Pract. 2006. PMID: 16984749

6

Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme: a report from the EORTC 26981/22981 NCI-C CE3 Intergroup Study.

Lamers LM, Stupp R, van den Bent MJ, Al MJ, Gorlia T, Wasserfallen JB, Mittmann N, Jin Seung S, Crott R, Uyl-de Groot CA; EORTC 26981/22981 NCI-C CE3 Intergroup Study. Lamers LM, et al. Cancer. 2008 Mar 15;112(6):1337-44. doi: 10.1002/cncr.23297. Cancer. 2008. PMID: 18213621 Free article. Clinical Trial.

7

Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death.

Wasserfallen JB, Ostermann S, Pica A, Mirimanoff RO, Leyvraz S, Villemure JG, Stupp R. Wasserfallen JB, et al. Cancer. 2004 Nov 1;101(9):2098-105. doi: 10.1002/cncr.20619. Cancer. 2004. PMID: 15389472 Free article.

8

The costs of managing patients with malignant glioma at a neuro-oncology clinic.

Latif AZ, Signorini D, Gregor A, Whittle IR. Latif AZ, et al. Br J Neurosurg. 1998 Apr;12(2):118-22. doi: 10.1080/02688699845230. Br J Neurosurg. 1998. PMID: 11013662

9

Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme.

Kovic B, Xie F. Kovic B, et al. J Clin Oncol. 2015 Jul 10;33(20):2296-302. doi: 10.1200/JCO.2014.59.7245. Epub 2015 May 26. J Clin Oncol. 2015. PMID: 26014296 Review.

10

A pilot cost-effectiveness analysis of treatments in newly diagnosed high-grade gliomas: the example of 5-aminolevulinic Acid compared with white-light surgery.

Esteves S, Alves M, Castel-Branco M, Stummer W. Esteves S, et al. Neurosurgery. 2015 May;76(5):552-62; discussion 562. doi: 10.1227/NEU.0000000000000673. Neurosurgery. 2015. PMID: 25714513 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

64 results

Results by year